These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 35203711)
21. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Steckelings UM; Sumners C Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709 [TBL] [Abstract][Full Text] [Related]
22. The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension. Huang Z; Cao J; Yao Y; Jin X; Luo Z; Xue Y; Zhu C; Song Y; Wang Y; Zou Y; Qian J; Yu K; Gong H; Ge J Ann Transl Med; 2020 Apr; 8(7):430. PubMed ID: 32395474 [TBL] [Abstract][Full Text] [Related]
23. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review. Singh B; Singh D; Verma V; Yadav R; Kumar R J Pharm Anal; 2022 Apr; 12(2):215-220. PubMed ID: 34934510 [TBL] [Abstract][Full Text] [Related]
25. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866 [TBL] [Abstract][Full Text] [Related]
26. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system. Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662 [TBL] [Abstract][Full Text] [Related]
27. Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe? Shylesh C M S; V S A; S K K; P UD Clin Exp Hypertens; 2022 Jan; 44(1):1-10. PubMed ID: 34414841 [No Abstract] [Full Text] [Related]
28. Timing matters in the use of renin-angiotensin system modulators and COVID-related cognitive and cerebrovascular dysfunction. Meier M; Becker S; Levine E; DuFresne O; Foster K; Moore J; Burnett FN; Hermanns VC; Heath SP; Abdelsaid M; Coucha M PLoS One; 2024; 19(7):e0304135. PubMed ID: 39074114 [TBL] [Abstract][Full Text] [Related]
30. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy? Aleksova A; Ferro F; Gagno G; Cappelletto C; Santon D; Rossi M; Ippolito G; Zumla A; Beltrami AP; Sinagra G J Intern Med; 2020 Oct; 288(4):410-421. PubMed ID: 32459372 [TBL] [Abstract][Full Text] [Related]
31. The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Bosso M; Thanaraj TA; Abu-Farha M; Alanbaei M; Abubaker J; Al-Mulla F Mol Ther Methods Clin Dev; 2020 Sep; 18():321-327. PubMed ID: 32665962 [TBL] [Abstract][Full Text] [Related]
32. Hypertension and COVID-19: Current Evidence and Perspectives. Gallo G; Calvez V; Savoia C High Blood Press Cardiovasc Prev; 2022 Mar; 29(2):115-123. PubMed ID: 35184271 [TBL] [Abstract][Full Text] [Related]
33. Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection. Sinha A; Vaggu RG; Swain R; Patnaik S Curr Microbiol; 2023 Apr; 80(6):194. PubMed ID: 37106165 [TBL] [Abstract][Full Text] [Related]
34. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19. Matsuzawa Y; Kimura K; Ogawa H; Tamura K Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments. Zolk O; Hafner S; Schmidt CQ; Naunyn Schmiedebergs Arch Pharmacol; 2020 Jul; 393(7):1131-1135. PubMed ID: 32415494 [TBL] [Abstract][Full Text] [Related]
36. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Rossi GP; Sanga V; Barton M Elife; 2020 Apr; 9():. PubMed ID: 32250244 [TBL] [Abstract][Full Text] [Related]
37. Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS. Gumashta J; Gumashta R Cureus; 2020 Jun; 12(6):e8411. PubMed ID: 32626626 [TBL] [Abstract][Full Text] [Related]
38. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System. Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994 [TBL] [Abstract][Full Text] [Related]
39. Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients. Farid Fahmy S; El Derany MO; Khorshid H; Saleh A; El-Demerdash E BMC Pharmacol Toxicol; 2023 Apr; 24(1):24. PubMed ID: 37060024 [TBL] [Abstract][Full Text] [Related]